Clinical Trials Logo

Filter by:
NCT ID: NCT01391156 Completed - Clinical trials for Androgenetic Alopecia

Efficacy Study of Minoxidil Lotion Versus Combined Minoxidil and Finasteride Lotion to Treat Male Pattern Hair Loss

Start date: March 2011
Phase: Phase 3
Study type: Interventional

The purpose of this study is to compare the efficacy of 3% Minoxidil lotion and 3% Minoxidil with 0.1% Finasteride lotion for 6 months in male pattern hair loss.

NCT ID: NCT01389986 Withdrawn - Paralytic Ileus Clinical Trials

Effects of Gum Chewing on Recovery of Bowel Function Following Abdominal Surgery for Endometrial and Ovarian Cancer

Start date: July 2011
Phase: Phase 2/Phase 3
Study type: Interventional

Following extensive abdominal surgery for the treatment of endometrial or ovarian cancer, paralytic ileus frequently develops. Gum chewing can promotes the return of bowel function through the cephalic-vagal reflex and increased intestinal enzymes secretion. The objectives of this study are to evaluate effects of adding gum chewing to the conventional postoperative feeding protocol on the return of bowel function, its related complications, and patients' satisfaction.

NCT ID: NCT01387542 Completed - Schizophrenia Clinical Trials

Safety and Efficacy Study of Paliperidone Extended Release (ER) Among Thai Schizophrenia Participants

PRESENT
Start date: August 2009
Phase: Phase 4
Study type: Interventional

The purpose of this study is to evaluate the effectiveness and safety of paliperidone extended release (ER) treatment in Thai schizophrenia (psychiatric disorder with symptoms of emotional instability, detachment from reality, often with delusions and hallucinations, and withdrawal into the self) participants.

NCT ID: NCT01387334 Completed - Type 2 Diabetes Clinical Trials

The Effectiveness of Resistance Exercise for Glycemic Control in Type 2 Diabetes Mellitus Patients

RE
Start date: February 2007
Phase: Phase 2
Study type: Interventional

Resistance exercise is effective in improving glycemic control in diabetes patients. The effectiveness of a home-based resistance exercise program has not been establish.

NCT ID: NCT01386528 Completed - Clinical trials for Congenital Bleeding Disorder

Efficacy and Safety of NNC-0156-0000-0009 During Surgical Procedures in Subjects With Haemophilia B

paradigmâ„¢ 3
Start date: June 7, 2012
Phase: Phase 3
Study type: Interventional

This trial is conducted in Africa, Asia, Europe and the United States of America (USA). The aim of the trial is to evaluate the safety and efficacy of NNC-0156-0000-0009 (nonacog beta pegol) during surgical procedures in patients with haemophilia B.

NCT ID: NCT01384682 Completed - HIV Clinical Trials

Maraviroc Switch Collaborative Study

MARCH
Start date: August 2011
Phase: Phase 4
Study type: Interventional

MARCH is an international, multicentre trial planning to enroll 380 HIV-1 infected patients who are currently on 2N(t)RTI + PI/r regimen and virologically suppressed. Participants will be randomized (1:2:2) to one of three treatment groups: to continue their current treatment regimen, maraviroc dose at 150 mg twice daily with PI/r, or maraviroc at 300 mg twice daily with 2N(t)RTI. As the participants population have HIV RNA <200 copies/mL, the phenotypic assessment of tropism cannot be used to determine tropism, instead we will employ the genotypic assessment of tropism by sequencing the V3 loop of the HIV envelope. The main aim of this study is to investigate whether switching to maraviroc, in combination with either RTI or PI/r, is as good at keeping the HIV viral load undetectable as the combination of RTI with PI/r. The other aim is to see if switching to these combinations with maraviroc will improve some of the side effects that can be seen when people take combination therapy including RTI and PI/r. The study hypothesis is that in stable, virologically suppressed (plasma HIV-RNA <200 copies/mL) patients with no history of prior virological failure, a switch to either MVC dosed at 300mg twice daily (bid) combined with the same 2N(t)RTI backbone regimen or MVC dosed at 150mg twice daily (bid) with the current PI/r (or 300mg bid at the discretion of the investigator if the PI/r is fosamprenavir/r) provides similar (non-inferior) antiretroviral efficacy compared to continuation of the current 2N(t)RTI + PI/r regimen.

NCT ID: NCT01381575 Completed - Clinical trials for Infections, Papillomavirus

Evaluation of Immunogenicity and Safety of Two 2-dose Human Papillomavirus (HPV) Vaccine Schedules in 9-14 Year Old Girls

Start date: June 29, 2011
Phase: Phase 3
Study type: Interventional

This study has been designed to evaluate the immunogenicity and safety of GSK Biologicals' HPV-16/18 vaccine when administered according to alternative 2-dose schedules (0,6 months and 0,12 months) in healthy 9-14 year old females as compared to the standard 3-dose schedule (0,1,6 months) in 15-25 year old females.

NCT ID: NCT01381484 Completed - Wrinkles Clinical Trials

Argireline in Treatment of Periorbital Wrinkles

Start date: March 2009
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine whether La Jolie gel is effective in the treatment of periorbital wrinkles.

NCT ID: NCT01380678 Recruiting - Inflammation Clinical Trials

Intralesional Bevacizumab Injection on Primary Pterygium

bevacizumab
Start date: January 2009
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate that intralesional injection of bevacizumab on primary pterygium can reduce the corneal pterygium area, inflammation, redness and other symptoms.

NCT ID: NCT01379521 Completed - Clinical trials for Hepatocellular Carcinoma

Safety and Efficacy of RAD001 + TACE in Localized Unresectable HCC

TRACER
Start date: June 2011
Phase: Phase 2
Study type: Interventional

This study will evaluate the role of everolimus in combination with local Transcatheter Arterial Chemoembolization (TACE) procedure in patients suffering from localized unresectable Hepatocellular Carcinoma (HCC).